# Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)

> **NCT02339974** · PHASE3 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 15 (actual)

## Conditions studied

- Tricuspid Regurgitation

## Interventions

- **DEVICE:** Heterotopic Implantation Of the Edwards-Sapien XT Transcatheter Valve in the Inferior VEna Cava

## Key facts

- **NCT ID:** NCT02339974
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339974, "Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02339974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*